These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 9506679

  • 1. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [Abstract] [Full Text] [Related]

  • 2. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [Abstract] [Full Text] [Related]

  • 3. Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1995 Jun; 25(6):853-61. PubMed ID: 7771481
    [Abstract] [Full Text] [Related]

  • 4. The alternative pathway C3 convertase and glomerular deposits.
    West CD, McAdams AJ.
    Pediatr Nephrol; 1999 Jun; 13(5):448-53. PubMed ID: 10412868
    [Abstract] [Full Text] [Related]

  • 5. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
    West CD, Witte DP, McAdams AJ.
    Am J Kidney Dis; 2001 Jun; 37(6):1120-30. PubMed ID: 11382679
    [Abstract] [Full Text] [Related]

  • 6. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
    Varade WS, Forristal J, West CD.
    Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 8. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2018 Aug; 9():2329. PubMed ID: 30487789
    [Abstract] [Full Text] [Related]

  • 9. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.
    J Pediatr; 1990 May; 116(5):S98-102. PubMed ID: 2329415
    [Abstract] [Full Text] [Related]

  • 10. Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
    Ohi H, Watanabe S, Fujita T, Seki M, Hatano M.
    J Immunol Methods; 1990 Jul 20; 131(1):71-6. PubMed ID: 2380570
    [Abstract] [Full Text] [Related]

  • 11. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
    Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.
    Clin J Am Soc Nephrol; 2011 May 20; 6(5):1009-17. PubMed ID: 21415311
    [Abstract] [Full Text] [Related]

  • 12. A hemolytic method for the measurement of nephritic factor.
    West CD.
    J Immunol Methods; 2008 Jun 01; 335(1-2):1-7. PubMed ID: 18410942
    [Abstract] [Full Text] [Related]

  • 13. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
    Carrara C, Podestà MA, Abbate M, Rizzo P, Piras R, Alberti M, Daina E, Ruggenenti P, Remuzzi G, on behalf of the EAGLE Study Group.
    Nephron; 2020 Jun 01; 144(4):195-203. PubMed ID: 32050203
    [Abstract] [Full Text] [Related]

  • 14. Nephritic factors predispose to chronic glomerulonephritis.
    West CD.
    Am J Kidney Dis; 1994 Dec 01; 24(6):956-63. PubMed ID: 7985676
    [Abstract] [Full Text] [Related]

  • 15. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar 01; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 16. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM, van de Kar NCAJ, van Kraaij SAW, Sarlea SA, Gracchi V, Engels FAPT, Dorresteijn EM, van der Deure J, Duineveld C, Wetzels JFM, van den Heuvel LPWJ, Volokhina EB.
    Front Immunol; 2021 Mar 01; 12():715704. PubMed ID: 34456924
    [Abstract] [Full Text] [Related]

  • 17. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
    Tanuma Y, Ohi H, Hatano M.
    Clin Immunol Immunopathol; 1990 Aug 01; 56(2):226-38. PubMed ID: 2143128
    [Abstract] [Full Text] [Related]

  • 18. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
    Meyers KE, Strife CF, Witzleben C, Kaplan BS.
    Am J Kidney Dis; 1996 Dec 01; 28(6):804-10. PubMed ID: 8957031
    [Abstract] [Full Text] [Related]

  • 19. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G, Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy, Nastasi.
    J Am Soc Nephrol; 2018 Jan 01; 29(1):283-294. PubMed ID: 29030465
    [Abstract] [Full Text] [Related]

  • 20. [Ultrastructural study on membranoproliferative glomerulonephritis with special reference to subepithelial deposits].
    Sato H.
    Nihon Jinzo Gakkai Shi; 1990 Sep 01; 32(9):973-83. PubMed ID: 2263028
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.